<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d279">
    <sentence id="DDI-DrugBank.d279.s0" text="The adverse effects of CAMPTOSAR, such as myelosuppression and diarrhea, would be expected to be exacerbated by other antineoplastic agents having similar adverse effects.">
        <entity charOffset="23-31" id="DDI-DrugBank.d279.s0.e0" text="CAMPTOSAR" type="brand"/>
        <entity charOffset="118-138" id="DDI-DrugBank.d279.s0.e1" text="antineoplastic agents" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d279.s0.e0" e2="DDI-DrugBank.d279.s0.e1" id="DDI-DrugBank.d279.s0.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s1" text="Patients who have previously received pelvic/ abdominal irradiation are at increased risk of severe myelosuppression following the administration of CAMPTOSAR.">
        <entity charOffset="149-157" id="DDI-DrugBank.d279.s1.e0" text="CAMPTOSAR" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s2" text="The concurrent administration of CAMPTOSAR with irradiation has not been adequately studied and is not recommended.">
        <entity charOffset="33-41" id="DDI-DrugBank.d279.s2.e0" text="CAMPTOSAR" type="brand"/>
    <negationtags>The concurrent administration of CAMPTOSAR with irradiation has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been adequately studied and is not recommended. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d279.s3" text="Lymphocytopenia has been reported in patients receiving CAMPTOSAR, and it is possible that the administration of dexamethasone as antiemetic prophylaxis may have enhanced the likelihood of this effect.">
        <entity charOffset="56-64" id="DDI-DrugBank.d279.s3.e0" text="CAMPTOSAR" type="brand"/>
        <entity charOffset="113-125" id="DDI-DrugBank.d279.s3.e1" text="dexamethasone" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d279.s3.e0" e2="DDI-DrugBank.d279.s3.e1" id="DDI-DrugBank.d279.s3.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s4" text="However, serious opportunistic infections have not been observed, and no complications have specifically been attributed to lymphocytopenia."><negationtags>However, serious opportunistic infections have &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been observed, and no complications have specifically been attributed to lymphocytopenia. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d279.s5" text="Hyperglycemia has also been reported in patients receiving CAMPTOSAR.">
        <entity charOffset="59-67" id="DDI-DrugBank.d279.s5.e0" text="CAMPTOSAR" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s6" text="Usually, this has been observed in patients with a history of diabetes mellitus or evidence of glucose intolerance prior to administration of CAMPTOSAR.">
        <entity charOffset="142-150" id="DDI-DrugBank.d279.s6.e0" text="CAMPTOSAR" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s7" text="It is probable that dexamethasone, given as antiemetic prophylaxis, contributed to hyperglycemia in some patients.">
        <entity charOffset="20-32" id="DDI-DrugBank.d279.s7.e0" text="dexamethasone" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s8" text="The incidence of akathisia in clinical trials of the weekly dosage schedule was greater (8.5%, 4/47 patients) when prochlorperazine was administered on the same day as CAMPTOSAR than when these drugs were given on separate days (1.3%, 1/80 patients).">
        <entity charOffset="115-130" id="DDI-DrugBank.d279.s8.e0" text="prochlorperazine" type="drug"/>
        <entity charOffset="168-176" id="DDI-DrugBank.d279.s8.e1" text="CAMPTOSAR" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d279.s8.e0" e2="DDI-DrugBank.d279.s8.e1" id="DDI-DrugBank.d279.s8.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s9" text="The 8.5% incidence of akathisia, however, is within the range reported for use of prochlorperazine when given as a premedication for other chemotherapies.">
        <entity charOffset="82-97" id="DDI-DrugBank.d279.s9.e0" text="prochlorperazine" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s10" text="It would be expected that laxative use during therapy with CAMPTOSAR would worsen the incidence or severity of diarrhea, but this has not been studied.">
        <entity charOffset="26-33" id="DDI-DrugBank.d279.s10.e0" text="laxative" type="group"/>
        <entity charOffset="59-67" id="DDI-DrugBank.d279.s10.e1" text="CAMPTOSAR" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d279.s10.e0" e2="DDI-DrugBank.d279.s10.e1" id="DDI-DrugBank.d279.s10.p0" type="effect"/>
    <negationtags>It would be expected that laxative use during therapy with CAMPTOSAR would worsen the incidence or severity of diarrhea, but this has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been studied. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d279.s11" text="In view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by CAMPTOSAR, the physician may wish to withhold diuretics during dosing with CAMPTOSAR and, certainly, during periods of active vomiting or diarrhea.">
        <entity charOffset="94-102" id="DDI-DrugBank.d279.s11.e0" text="CAMPTOSAR" type="brand"/>
        <entity charOffset="140-148" id="DDI-DrugBank.d279.s11.e1" text="diuretics" type="group"/>
        <entity charOffset="169-177" id="DDI-DrugBank.d279.s11.e2" text="CAMPTOSAR" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d279.s11.e0" e2="DDI-DrugBank.d279.s11.e1" id="DDI-DrugBank.d279.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d279.s11.e0" e2="DDI-DrugBank.d279.s11.e2" id="DDI-DrugBank.d279.s11.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d279.s11.e1" e2="DDI-DrugBank.d279.s11.e2" id="DDI-DrugBank.d279.s11.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d279.s12" text="Drug-Laboratory Test Interactions There are no known interactions between CAMPTOSAR and laboratory tests.">
        <entity charOffset="74-82" id="DDI-DrugBank.d279.s12.e0" text="CAMPTOSAR" type="brand"/>
    <negationtags>Drug-Laboratory Test Interactions There are &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; known interactions between CAMPTOSAR and laboratory tests. &lt;/scope&gt;</negationtags></sentence>
</document>